EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeted nanoliposomes for the delivery of boronophenylalanine into HER2-positive cells

G M Proshkina, E I Shramova, A B Mirkasymov, I N Zavestovskaya, S M Deyev

Acta Naturae · 14.10.2025 · 17 (3) · 88-93

DOI: 10.32607/actanaturae.27722 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Naturae, online erschienen am 14.10.2025. Verfasst von G M Proshkina und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Research Center "Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS", Moscow, 117997 Russia. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Boron neutron capture therapy (BNCT) is a rapidly developing field of radiation therapy for cancer that is based on the accumulation of the radiosensitive 10B isotope in cancer cells, followed by tumor irradiation with thermal neutrons. Widespread use of BNCT in clinical practice remains limited because of the poor accumulation of boron-containing (10B) drugs in the tumor or their high toxicity to the body. This study focuses on the engineering of tumor-specific liposomes loaded with 4-L-boronophenylalanine (4-L-10BPA) for application in boron neutron capture therapy. According to the spectrophotometry and ICP-mass spectroscopy data, the 4-L-10BPA-to-liposome molar ratio is ~ 120,000. Liposomal targeting of human epidermal growth factor receptor 2 (HER2) was determined by HER2-specific designed ankyrin repeat protein (DARPin)_9-29 on the outer surface of liposomes. DARPin-modified liposomes were found to bind to HER2-overexpressing cells and be effectively internalized into the cytoplasm. The ability of DARPin-functionalized liposomes to precision-deliver large quantities of 4-L-10BPA into cancer cells may open up new prospects for BNCT.

Schlagwörter

Stichwörter der Autor:innen

4-L-10BPAHER2-specific therapyboron neutron capture therapyliposomes

Autor:innen und Institutionen

  • State Research Center "Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS", Moscow, 117997 Russia.
  • Lebedev Physical Institute RAS, Moscow, 119991 Russia.
  • National Research Center "Kurchatov Institute", Moscow, 123098 Russia.
  • Moscow Institute of Engineering Physics, National Research Nuclear University "MEPhI", Moscow, 115409 Russia.
  • Ogarev National Research Mordovia State University, Saransk, 430005 Russia.

Zitieren

APA

Proshkina, G. M., Shramova, E. I., Mirkasymov, A. B., Zavestovskaya, I. N., & Deyev, S. M. (2025). Targeted nanoliposomes for the delivery of boronophenylalanine into HER2-positive cells. Acta Naturae, 17(3), 88-93. https://doi.org/10.32607/actanaturae.27722

Vancouver

Proshkina GM, Shramova EI, Mirkasymov AB, Zavestovskaya IN, Deyev SM. Targeted nanoliposomes for the delivery of boronophenylalanine into HER2-positive cells. Acta Naturae. 2025;17(3):88-93. doi:10.32607/actanaturae.27722

BibTeX
@article{Proshkina2025,
  author = {Proshkina, G M and Shramova, E I and Mirkasymov, A B and Zavestovskaya, I N and Deyev, S M},
  title = {Targeted nanoliposomes for the delivery of boronophenylalanine into HER2-positive cells},
  journal = {Acta Naturae},
  year = {2025},
  volume = {17},
  number = {3},
  pages = {88--93},
  doi = {10.32607/actanaturae.27722}
}
Kostenlos starten →